AAAAAA

   
Results: 1-12 |
Results: 12
INSULIN-TREATMENT INHIBITS PAI-1 PRODUCTION IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION
Authors: GALAJDA P BALAZ D MARTINKA E MOKAN M KUBISZ P
Citation: P. Galajda et al., INSULIN-TREATMENT INHIBITS PAI-1 PRODUCTION IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 250-252
PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) LEVELS ARE DECREASED IN NIDDM PATIENTS TREATED WITH INSULIN
Authors: GALAJDA P MARTINKA E STASKO J MOKAN M KUBISZ P
Citation: P. Galajda et al., PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) LEVELS ARE DECREASED IN NIDDM PATIENTS TREATED WITH INSULIN, Clinical and applied thrombosis/hemostasis, 4(2), 1998, pp. 138-139
ENDOGENOUS DIGOXIN-LIKE IMMUNOACTIVITY IN SUBJECTS WITH DIABETES-MELLITUS AND HYPERTENSION
Authors: MARTINKA E OCENASOVA A KAMENISTIAKOVA L DOBROTA D KERNY J MOKAN M
Citation: E. Martinka et al., ENDOGENOUS DIGOXIN-LIKE IMMUNOACTIVITY IN SUBJECTS WITH DIABETES-MELLITUS AND HYPERTENSION, American journal of hypertension, 11(6), 1998, pp. 667-676
PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS WITH ENDOTHELIAL DYSFUNCTION
Authors: GALAJDA P BALAZ D MARTINKA E SUTARIK C KUBISZ P MOKAN M
Citation: P. Galajda et al., PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS WITH ENDOTHELIAL DYSFUNCTION, Diabetologia, 41, 1998, pp. 1273-1273
SCLEREDEMA DIABETICORUM IN A PATIENT WITH LATENT AUTOIMMUNE DIABETES IN ADULTS (LADA)
Authors: PEC J FETISOVOVA Z FRLICKOVA Z ADAMICOVA K STRAKOVA J MACKOVA N MARTINKA E MOKAN M DOBROTA D PEC M
Citation: J. Pec et al., SCLEREDEMA DIABETICORUM IN A PATIENT WITH LATENT AUTOIMMUNE DIABETES IN ADULTS (LADA), EJD. European journal of dermatology, 7(8), 1997, pp. 596-598
PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN NIDDM
Authors: GALAJDA P MARTINKA E BALAZ D KERNY J STASKO J MOKAN M KUBISZ P
Citation: P. Galajda et al., PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN NIDDM, Thrombosis and haemostasis, 1997, pp. 1464-1464
ENDOGENOUS DIGOXIN-LIKE IMMUNOACTIVITY AND DIABETES-MELLITUS - FACTS AND HYPOTHESES
Authors: MARTINKA E GALAJADA P OCHODNICKY M LICHARDUS B STRAKA S MOKAN M
Citation: E. Martinka et al., ENDOGENOUS DIGOXIN-LIKE IMMUNOACTIVITY AND DIABETES-MELLITUS - FACTS AND HYPOTHESES, Medical hypotheses, 49(3), 1997, pp. 271-275
ENDOTHELIAL MARKERS IN DIABETES-MELLITUS
Authors: GALAJDA P MARTINKA E MOKAN M KUBISZ P
Citation: P. Galajda et al., ENDOTHELIAL MARKERS IN DIABETES-MELLITUS, Thrombosis research, 85(1), 1997, pp. 63-65
DIGOXIN-LIKE IMMUNOACTIVITY IN PREGNANT-WOMEN WITH DIABETES-MELLITUS
Authors: MARTINKA E OCHODNICKY M MOKAN M
Citation: E. Martinka et al., DIGOXIN-LIKE IMMUNOACTIVITY IN PREGNANT-WOMEN WITH DIABETES-MELLITUS, American journal of hypertension, 9(5), 1996, pp. 516-516
ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS
Authors: MARTINKA E GALAJDA P MOKAN M
Citation: E. Martinka et al., ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS, Diabetologia, 39, 1996, pp. 670-670
FIBRINOLYTIC PARAMETERS IN RELATION TO C-PEPTIDE AND ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS
Authors: MOKAN M MARTINKA E GALAJDA P KUBISZ P
Citation: M. Mokan et al., FIBRINOLYTIC PARAMETERS IN RELATION TO C-PEPTIDE AND ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS, Diabetologia, 39, 1996, pp. 904-904
DIGOXIN-LIKE IMMUNOACTIVITY AND GLUCOSE-TOLERANCE IN PREGNANCY
Authors: MARTINKA E MATUSEK J OCHODNICKY M KVETENSKY J GALAJDA P MOKAN M
Citation: E. Martinka et al., DIGOXIN-LIKE IMMUNOACTIVITY AND GLUCOSE-TOLERANCE IN PREGNANCY, Diabetes, nutrition & metabolism, 6(4), 1993, pp. 189-194
Risultati: 1-12 |